168 related articles for article (PubMed ID: 35723682)
1. Medication prescribing for alcohol use disorders during alcohol-related encounters in a Colorado regional healthcare system.
Chockalingam L; Burnham EL; Jolley SE
Alcohol Clin Exp Res; 2022 Jun; 46(6):1094-1102. PubMed ID: 35723682
[TBL] [Abstract][Full Text] [Related]
2. Impact of a pharmacist-led substance use disorder transitions of care clinic on postdischarge medication treatment retention.
Smith A; Hansen J; Colvard M
J Subst Abuse Treat; 2021 Nov; 130():108440. PubMed ID: 34118708
[TBL] [Abstract][Full Text] [Related]
3. Addiction Consult Service and Inpatient Outcomes Among Patients with Alcohol Use Disorder.
Singh-Tan S; Torres-Lockhart K; Jakubowski A; Lu T; Starrels J; De Lima P; Arnsten J; Nahvi S; Southern W
J Gen Intern Med; 2023 Nov; 38(14):3216-3223. PubMed ID: 37100986
[TBL] [Abstract][Full Text] [Related]
4. Outcomes After Initiation of Medications for Alcohol Use Disorder at Hospital Discharge.
Bernstein EY; Baggett TP; Trivedi S; Herzig SJ; Anderson TS
JAMA Netw Open; 2024 Mar; 7(3):e243387. PubMed ID: 38551564
[TBL] [Abstract][Full Text] [Related]
5. Trends in the Use of Naltrexone for Addiction Treatment among Alcohol Use Disorder Admissions in U.S. Substance Use Treatment Facilities.
Qeadan F; Mensah NA; Gu LY; Madden EF; Venner KL; English K
Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444639
[TBL] [Abstract][Full Text] [Related]
6. Predictors of initiation of and retention on medications for alcohol use disorder among people living with and without HIV.
Oldfield BJ; McGinnis KA; Edelman EJ; Williams EC; Gordon AJ; Akgün K; Crystal S; Fiellin LE; Gaither JR; Goulet JL; Korthuis PT; Marshall BDL; Justice AC; Bryant K; Fiellin DA; Kraemer KL
J Subst Abuse Treat; 2020 Feb; 109():14-22. PubMed ID: 31856946
[TBL] [Abstract][Full Text] [Related]
7. Using a cascade of care framework to identify gaps in access to medications for alcohol use disorder in British Columbia, Canada.
Socias ME; Scheuermeyer FX; Cui Z; Mok WY; Crabtree A; Fairbairn N; Nolan S; Slaunwhite A; Ti L
Addiction; 2023 Nov; 118(11):2128-2138. PubMed ID: 37488683
[TBL] [Abstract][Full Text] [Related]
8. Association of Opioid Use Disorder Treatment With Alcohol-Related Acute Events.
Xu KY; Presnall N; Mintz CM; Borodovsky JT; Bhat NR; Bierut LJ; Grucza RA
JAMA Netw Open; 2021 Feb; 4(2):e210061. PubMed ID: 33625511
[TBL] [Abstract][Full Text] [Related]
9. Medications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis.
Rabiee A; Mahmud N; Falker C; Garcia-Tsao G; Taddei T; Kaplan DE
Hepatol Commun; 2023 Apr; 7(4):. PubMed ID: 36972386
[TBL] [Abstract][Full Text] [Related]
10. Prescribing Medications for Alcohol Use Disorder: A Qualitative Study of Primary Care Physician Decision Making.
Bhardwaj A; Sousa JL; Huskamp HA; Busch AB; Kennedy-Hendricks A; Hodgkin D; Horgan C; Uscher-Pines L
Ann Fam Med; 2023; 21(4):332-337. PubMed ID: 37487716
[TBL] [Abstract][Full Text] [Related]
11. Predictors of Opioid and Alcohol Pharmacotherapy Initiation at Hospital Discharge Among Patients Seen by an Inpatient Addiction Consult Service.
Englander H; King C; Nicolaidis C; Collins D; Patten A; Gregg J; Korthuis PT
J Addict Med; 2020; 14(5):415-422. PubMed ID: 31868830
[TBL] [Abstract][Full Text] [Related]
12. Implementation and analysis of a multifaceted intervention for alcohol use disorder from a single academic urban emergency department.
Duvalyan E; Falade I; Fan W; Foe M; Mvemba A; Zussman JW; Geier C; LeSaint KT; Graglia S
Acad Emerg Med; 2024 May; 31(5):456-462. PubMed ID: 38380769
[TBL] [Abstract][Full Text] [Related]
13. A rapid access to addiction medicine clinic facilitates treatment of substance use disorder and reduces substance use.
Wiercigroch D; Sheikh H; Hulme J
Subst Abuse Treat Prev Policy; 2020 Jan; 15(1):4. PubMed ID: 31931831
[TBL] [Abstract][Full Text] [Related]
14. Attitudes about medications for alcohol use disorder among individuals with serious mental illness: A health belief model analysis.
Bromley E; Tarn DM; McCreary M; Hurley B; Ober AJ; Watkins KE
J Subst Abuse Treat; 2020 Jul; 114():108007. PubMed ID: 32527506
[TBL] [Abstract][Full Text] [Related]
15. Comparison of healthcare utilization among patients treated with alcoholism medications.
Mark TL; Montejano LB; Kranzler HR; Chalk M; Gastfriend DR
Am J Manag Care; 2010; 16(12):879-88. PubMed ID: 21348558
[TBL] [Abstract][Full Text] [Related]
16. National outpatient medication utilization for opioid and alcohol use disorders from 2014 to 2016.
Evoy KE; Roccograndi L; Le S; Leonard CE; Covvey JR; Ochs L; Peckham AM; Soprano SE; Reveles KR
J Subst Abuse Treat; 2020 Dec; 119():108141. PubMed ID: 33138926
[TBL] [Abstract][Full Text] [Related]
17. Initiation of Medication for Alcohol Use Disorder for Inpatients with Alcohol Withdrawal Syndromes.
Krimpuri R; Youngs C; Emerman C
J Stud Alcohol Drugs; 2023 Mar; 84(2):293. PubMed ID: 36971765
[TBL] [Abstract][Full Text] [Related]
18. Addition of a clinical pharmacist practitioner to an inpatient addiction triage team and related medication outcomes.
Ehrhard K; Colvard M; Brabson J
Ment Health Clin; 2022 Aug; 12(4):219-224. PubMed ID: 36071740
[TBL] [Abstract][Full Text] [Related]
19. Prescription procedures in medication for relapse prevention after inpatient treatment for alcohol use disorders in Switzerland.
Buri C; Moggi F; Giovanoli A; Strik W
Alcohol Alcohol; 2007; 42(4):333-9. PubMed ID: 17517820
[TBL] [Abstract][Full Text] [Related]
20. Impact of behavioral and medication treatment for alcohol use disorder on changes in HIV-related outcomes among patients with HIV: A longitudinal analysis.
McGinnis KA; Skanderson M; Edelman EJ; Gordon AJ; Korthuis PT; Oldfield B; Williams EC; Wyse J; Bryant K; Fiellin DA; Justice AC; Kraemer KL
Drug Alcohol Depend; 2020 Dec; 217():108272. PubMed ID: 32971391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
